Stay updated on Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page
- Check4 days agoChange DetectedThe history page now shows Revision: v3.3.3 and removes the HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page history now shows revision label v3.3.2 replacing v3.3.1, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedA new revision entry v3.3.1 was added and the v3.2.0 entry was removed from the history.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoval of the site-wide notice about government funding and operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check54 days agoChange DetectedOld and new screenshots show the same version entries with no substantive changes to the study data, indicating a UI/visual refresh rather than content updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and guidance for users.SummaryDifference10%

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page.